Clinical pearl: Expanding knowledge of emergency contraception among dermatologists

Jessica Wu, BA; Yasmin Qaseem, MD; Ron Birnbaum, MD; Jan Smogorzewski, MD

International Journal of Women's Dermatology (Dec 2020)

Clinical pearl: Expanding knowledge of emergency contraception among dermatologists

Jessica Wu, BA,
Yasmin Qaseem, MD,
Ron Birnbaum, MD,
Jan Smogorzewski, MD

Affiliations

Jessica Wu, BA: David Geffen School of Medicine, University of California, Los Angeles, CA, United States
Yasmin Qaseem, MD: Division of Dermatology, Harbor-UCLA Medical Center, Los Angeles, CA, United States
Ron Birnbaum, MD: Division of Dermatology, Harbor-UCLA Medical Center, Los Angeles, CA, United States
Jan Smogorzewski, MD: Division of Dermatology, Harbor-UCLA Medical Center, Los Angeles, CA, United States; Corresponding author.

Journal volume & issue: Vol. 6, no. 5
pp. 450 – 451

Abstract

Read online

Dermatologists prescribe teratogenic or potentially teratogenic medications to treat a variety of skin diseases, including spironolactone for hormonal dysregulation in hidradenitis suppurativa or isotretinoin for severe acne. Although contraceptive options are regularly discussed, dermatologists must also be familiar with emergency contraceptive methods in the case that patients receiving teratogenic medications engage in unprotected sexual intercourse and do not desire pregnancy. A lack of knowledge regarding emergency contraceptive options may represent a practice gap for dermatologists.

Published in International Journal of Women's Dermatology

ISSN: 2352-6475 (Online)
Publisher: Wolters Kluwer
Country of publisher: United States
LCC subjects: Medicine: Dermatology
Website: https://journals.lww.com/ijwd/pages/default.aspx

About the journal

Abstract

Keywords